Allergy and Immunization CME

Convenient Allergy & Immunology CME

The Brigham Board Review in Allergy & Immunology online CME course provides in-depth coverage of a range of practice improvement areas to help you stay on top of the latest advances in the field. This online CME course includes case-based lectures on topics like ocular allergies, skin testing, asthma, anaphylaxis, dermatitis, mastocytosis, immunodeficiencies and more. It’s continuing medical education that will help you:

• Integrate and demonstrate improved understanding of allergy/immunologic diseases
• Identify and improve clinical competence-based practice gaps in allergy/immunology
• Correlate pathophysiology and pathobiologic principles with clinical presentations
• Describe optimal therapeutic strategies and their risks and benefits
• Apply the knowledge and strategies gained to the board exam and daily practice

Learning Objectives

After viewing this activity, participants will demonstrate the ability to:

• Integrate and demonstrate increased overall knowledge of allergy/immunologic diseases
• Identify and improve knowledge and clinical competence-based practice gaps in allergy/immunology
• Correlate pathophysiology and pathobiologic principles with clinical presentations
• Describe optimal therapeutic strategies and their risks and benefits
• Apply the knowledge and strategies gained through participation in this activity to the board exam and daily practice

Intended Audience

This educational activity was designed for fellows/trainees and practicing allergists/immunologists and other professional affiliates, such as internists, with an interest in allergy/immunology or who seek CME in an attempt to improve patient care.

Stay on top of your game with the StatPearls Physician Unlimited CME programs. With 6,046 activities, StatPearls is the largest CME provider in the world. These Pub-Med Indexed articles are categorized into 162 specialty areas which lets you better access activities that will make the biggest impact on your practice. One subscription allows access to all the activities, including all state-requirements.

Pricing Options

• 6 Month subscription: All 6,339 CME Activities – $249 per 6 months
• Annual subscription: All 6,339 CME Activities – $349 per 1 year
• Lifetime: All 6,339 CME Activities + Access to Board Reviews Forever – $1999

Physicians specializing in Allergy or Dermatology.

Target Audience:
Physicians specializing in Immunology, Nephrology, Urology

Treatment Updates on Chronic Inflammatory Demyelinating Polyneuropathy emphasizes the use of IVIg in the treatment of Chronic Inflammatory Demyelinating Polyneuropathy.

The presentation consists of a single lecture, Treatment Updates on Chronic Inflammatory Demyelinating Polyneuropathy, with discussion by Roy L. Freeman, MD, Richard J. Barohn, MD and Kenneth C. Gorson, MD.

After viewing Treatment Updates on Chronic Inflammatory Demyelinating Polyneuropathy, you will be better able to :
• Conduct a thorough and timely evaluation and differential diagnosis of patients with chronic inflammatory demyelinating polyneuropathy.
• Devise appropriate treatment regimen for the effective management of chronic inflammatory polyneuropathy based on guidelines and clinical evidence.

Target Audiences:
This program is intended for US-based neurologists, immunologists, physician assistants, nurse practitioners, and nurses who manage, or have an interest in managing patients with immune-mediated neuropathies.

Some popular articles and quizzes include:
• Gene-environment interactions in asthma and allergic diseases
• Allergy to B-lactam antibiotics
• Molecular mechanisms of mucocutaneous immunity against Candida and Staphylococcus species
• Cutaneous drug reactions
• IL-13 in asthma and allergic disease: Asthma phenotypes and targeted therapies
• Evaluation and management of a patient with chronic pruritus
• Human versus mouse eosinophils

Target Audience: Physicians focusing on Allergy, Chest Medicine

CME activities of special interest to allergists and immunologists. Medscape contains a variety of educational formats:

CONFERENCE COVERAGE – Reports of advances presented at major medical conferences; typically includes several tracks with news stories, expert interviews, and in-depth topic overviews.

CLINICAL UPDATE – Comprehensive original review article on scientific advances in a clinical topic.

FAST TRACK CLINICAL UPDATE – Narrowly focused original review article on scientific advances in a clinical topic.

CME-LIVE – Real-time online events with streaming video, synchronized visuals, and interactive questions and answers; archived for 1 year.
CLINICAL BRIEFS – Daily reports of major current medical research articles; 0.25 credits each

JOURNAL CME – Articles selected from a wide selection of peer-reviewed journals.
SPECIAL REPORT CME – Topic-based monthly email newsletter distributed to Medscape’s professional member database by specialty.

INTERACTIVE PATIENT CASES – Original CME activity presented to the physician in an interactive, clinical case-based format. (See especially eMedicine CME Case Presentations.)

CME CIRCLE – Multimedia content certified by other accredited professional education providers, typically from live symposia or monographs, and then posted on Medscape and archived for one year.

Target Audience: ALLG

Target Audience: Physicians focusing on Allergy or Dermatology

This Pediatrics and Allergy CME course contains 3 activities and offers 0.75 AMA PRA Category 1 Credits™.

After completing this course, you will better be able to:

• Assess the burden of food allergy in children.
• Evaluate appropriate tools and strategies for the diagnosis and management of children with IgE-mediated food allergy.
• Examine the comparative benefits and limitations of available and emerging methods for immunotherapy for the treatment of food allergy in children.
• Explain the clinical and practical significance of increasing the allergen response threshold via immunotherapy.

Activity Description / Statement of Need:

In this online, self-learning activity:

Atopic dermatitis (AD) is a chronic, highly pruritic inflammatory skin disease that is one of the most common skin disorders in children but may develop at any age. It affects 15-30% of children and two to ten percent of adults in developed countries, and between 10-30% of children who have the condition continue to experience it in adulthood. AD is thought to arise from a complicated interplay between multiple genes and environmental triggers, with known risk factors including family history and loss of function mutations in filaggrin. Complications include food allergy, asthma, and allergic rhinitis, and aside from genetics, its pathophysiology involves T-cell mediated inflammation and epidermal dysfunction. The disease is associated with a considerable healthcare burden placed on patients and their families; pruritis aside, patients not uncommonly suffer a loss of sleep and experience secondary infections, anxiety, and depression.

Target Audience:

The following HCPs: Pediatric and adult dermatologists, allergists, and internists; physician assistants, nurse practitioners, and pharmacists who treat patients with dermatologic conditions; and any other HCPs with an interest in or who diagnose, treat, or manage patients with AD.